![](/img/cover-not-exists.png)
FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
O'Leary, Maura C., Lu, Xiaobin, Huang, Ying, Lin, Xue, Mahmood, Iftekhar, Przepiorka, Donna, Gavin, Denise, Lee, Shiowjen, Liu, Ke, George, Bindu, Bryan, Wilson, Theoret, Marc R., Pazdur, RichardLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-2035
Date:
October, 2018
File:
PDF, 470 KB
english, 2018